Promentis Pharmaceuticals Inc. of Milwaukee, which is developing compounds for treating schizophrenia and other central nervous system disorders, has attracted $2.9 million in a second round of capital-raising. Read the full Milwaukee Business Journal story here.
Milwaukee Biz Journal: Promentis Pharmaceuticals raises $2.9M
by Tech Council | Jan 16, 2014 | Featured, NEWSROOM, Tech Council News